RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.19), $0.24 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.55 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.